Vimian Group completed the acquisition of an 80% stake in iM3 for €144m.

Vimian Group, an animal health company, completed the acquisition of an 80% stake in iM3, a manufacturer of veterinary dental equipment for €144m. “The acquisition of a majority of iM3 represents an important milestone on our journey to create a global leader in veterinary MedTech and marks our entrance into a new niche with significant unmet medical needs," Patrik Eriksson, Vimian Group CEO.